Royal Bank of Canada’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.65M | Sell |
154,876
-5,806
| -4% | -$231K | ﹤0.01% | 2376 |
|
|
2026
Q1 | $6.19M | Buy |
160,682
+218
| +0.1% | +$8.99K | ﹤0.01% | 2252 |
|
|
2025
Q4 | $6.6M | Buy |
160,464
+18,442
| +13% | +$728K | ﹤0.01% | 2224 |
|
|
2025
Q3 | $5.29M | Buy |
142,022
+818
| +0.6% | +$29.7K | ﹤0.01% | 2628 |
|
|
2025
Q2 | $5.15M | Sell |
141,204
-2,342
| -2% | -$84.9K | ﹤0.01% | 2550 |
|
|
2025
Q1 | $5.55M | Buy |
143,546
+684
| +0.5% | +$27.1K | ﹤0.01% | 2176 |
|
|
2024
Q4 | $5.42M | Sell |
142,862
-6,440
| -4% | -$257K | ﹤0.01% | 2252 |
|
|
2024
Q3 | $6.26M | Buy |
149,302
+16,013
| +12% | +$665K | ﹤0.01% | 2105 |
|
|
2024
Q2 | $5.45M | Sell |
133,289
-4,049
| -3% | -$161K | ﹤0.01% | 2115 |
|
|
2024
Q1 | $5.69M | Buy |
137,338
+11,923
| +10% | +$499K | ﹤0.01% | 2074 |
|
|
2023
Q4 | $5.07M | Buy |
125,415
+14,646
| +13% | +$559K | ﹤0.01% | 2220 |
|
|
2023
Q3 | $4.34M | Buy |
110,769
+12,862
| +13% | +$512K | ﹤0.01% | 2205 |
|
|
2023
Q2 | $3.98M | Buy |
97,907
+2,110
| +2% | +$86.8K | ﹤0.01% | 2275 |
|
|
2023
Q1 | $4.01M | Buy |
95,797
+852
| +0.9% | +$35.8K | ﹤0.01% | 2250 |
|
|
2022
Q4 | $4.14M | Buy |
94,945
+1,938
| +2% | +$82.4K | ﹤0.01% | 2291 |
|
|
2022
Q3 | $3.61M | Buy |
93,007
+6,059
| +7% | +$258K | ﹤0.01% | 2341 |
|
|
2022
Q2 | $3.69M | Buy |
86,948
+1,968
| +2% | +$85.5K | ﹤0.01% | 2352 |
|
|
2022
Q1 | $3.87M | Sell |
84,980
-2,026
| -2% | -$89.8K | ﹤0.01% | 2469 |
|
|
2021
Q4 | $4.22M | Sell |
87,006
-1,960
| -2% | -$92.8K | ﹤0.01% | 2514 |
|
|
2021
Q3 | $4.24M | Sell |
88,966
-36,894
| -29% | -$1.8M | ﹤0.01% | 2428 |
|
|
2021
Q2 | $6.1M | Buy |
125,860
+2,143
| +2% | +$102K | ﹤0.01% | 2186 |
|
|
2021
Q1 | $5.72M | Buy |
123,717
+4
| +0% | +$190 | ﹤0.01% | 2138 |
|
|
2020
Q4 | $5.89M | Buy |
123,713
+746
| +0.6% | +$33.8K | ﹤0.01% | 2081 |
|
|
2020
Q3 | $5.27M | Sell |
122,967
-12,919
| -10% | -$553K | ﹤0.01% | 1969 |
|
|
2020
Q2 | $5.54M | Buy |
135,886
+2,312
| +2% | +$93.3K | ﹤0.01% | 1874 |
|
|
2020
Q1 | $4.82M | Buy |
133,574
+57,937
| +77% | +$2.31M | ﹤0.01% | 1830 |
|
|
2019
Q4 | $3.21M | Buy |
75,637
+2,194
| +3% | +$87K | ﹤0.01% | 2471 |
|
|
2019
Q3 | $2.81M | Buy |
73,443
+2,440
| +3% | +$93.9K | ﹤0.01% | 2486 |
|
|
2019
Q2 | $2.76M | Sell |
71,003
-1,506
| -2% | -$57.2K | ﹤0.01% | 2517 |
|
|
2019
Q1 | $2.88M | Sell |
72,509
-117
| -0.2% | -$4.63K | ﹤0.01% | 2417 |
|
|
2018
Q4 | $2.65M | Sell |
72,626
-1,633
| -2% | -$64.2K | ﹤0.01% | 2443 |
|
|
2018
Q3 | $3.16M | Buy |
74,259
+7,416
| +11% | +$301K | ﹤0.01% | 2494 |
|
|
2018
Q2 | $2.58M | Buy |
66,843
+2,746
| +4% | +$99.5K | ﹤0.01% | 2535 |
|
|
2018
Q1 | $2.24M | Buy |
64,097
+3,991
| +7% | +$142K | ﹤0.01% | 2603 |
|
|
2017
Q4 | $2.19M | Buy |
60,106
+6,243
| +12% | +$226K | ﹤0.01% | 2653 |
|
|
2017
Q3 | $1.96M | Buy |
53,863
+3,955
| +8% | +$144K | ﹤0.01% | 2676 |
|
|
2017
Q2 | $1.83M | Buy |
49,908
+7,610
| +18% | +$267K | ﹤0.01% | 2659 |
|
|
2017
Q1 | $1.46M | Sell |
42,298
-1,507
| -3% | -$50.7K | ﹤0.01% | 2787 |
|
|
2016
Q4 | $1.39M | Buy |
43,805
+2,105
| +5% | +$70.5K | ﹤0.01% | 2867 |
|
|
2016
Q3 | $1.42M | Buy |
41,700
+1,017
| +2% | +$35.9K | ﹤0.01% | 2816 |
|
|
2016
Q2 | $1.45M | Sell |
40,683
-18,205
| -31% | -$666K | ﹤0.01% | 2800 |
|
|
2016
Q1 | $2.09M | Sell |
58,888
-25,352
| -30% | -$895K | ﹤0.01% | 2423 |
|
|
2015
Q4 | $3.31M | Sell |
84,240
-134
| -0.2% | -$5.46K | ﹤0.01% | 2151 |
|
|
2015
Q3 | $3.17M | Buy |
84,374
+390
| +0.5% | +$17.2K | ﹤0.01% | 1881 |
|
|
2015
Q2 | $3.6M | Buy |
83,984
+3,535
| +4% | +$152K | ﹤0.01% | 1835 |
|
|
2015
Q1 | $3.46M | Sell |
80,449
-2,294
| -3% | -$95.7K | ﹤0.01% | 1847 |
|
|
2014
Q4 | $3.53M | Buy |
82,743
+5,072
| +7% | +$209K | ﹤0.01% | 1882 |
|
|
2014
Q3 | $2.98M | Buy |
77,671
+2,460
| +3% | +$90.5K | ﹤0.01% | 1999 |
|
|
2014
Q2 | $2.76M | Buy |
75,211
+5,966
| +9% | +$216K | ﹤0.01% | 2055 |
|
|
2014
Q1 | $2.56M | Sell |
69,245
-4,133
| -6% | -$152K | ﹤0.01% | 2065 |
|
|
2013
Q4 | $2.6M | Buy |
73,378
+1,332
| +2% | +$44.8K | ﹤0.01% | 2095 |
|
|
2013
Q3 | $2.35M | Buy |
72,046
+1,513
| +2% | +$50.2K | ﹤0.01% | 2094 |
|
|
2013
Q2 | $2.19M | Buy |
+70,533
| New | +$2.2M | ﹤0.01% | 1993 |
|
Other funds holding BME
1CP
NRW
KIM
Royal Bank of Canada's BME Position: Q2 2026 in Review
Royal Bank of Canada reduced its BlackRock Health Sciences Trust (BME) stake by 3.6% in Q2 2026, selling an estimated $231K and leaving 154,876 shares worth $6.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.
Royal Bank of Canada first reported a position in BME in Q2 2013 and has held it in 53 quarters since. 78 funds tracked by Wall St. Rank hold BME as of Q2 2026.
- Royal Bank of Canada held 154,876 shares of BlackRock Health Sciences Trust worth $6.65M as of Q2 2026.
- Royal Bank of Canada sold 5,806 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $231K.
- BlackRock Health Sciences Trust made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #2376 holding.
- Royal Bank of Canada first reported a position in BlackRock Health Sciences Trust in Q2 2013 and has held it in 53 quarters since.
- 78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.